Searched for
GLOBAL RESEARCH BASED PHARMACEUTICAL
Prasol Chemicals IPO Day 3: Check GMP, subscription status and other detailsPrasol Chemicals IPO enters its final bidding day with muted demand and zero GMP, pointing to expectations of a flat listing. The Rs 500 cr...- Novartis India MD Amitabh Dube appointed as OPPI presidentAmitabh Dube has been appointed as the new president of OPPI for a two-year term. Dube currently serves as the Country President and Managi...
- Dividend alert! Last day to buy IREDA, Kalyan Jewellers among more than 100 stocks for dividends. Do you own any?Under Sebi's T+1 settlement cycle, investors need to purchase a company's shares at least one trading day before the record date to ensure ...
- Beyond Los Angeles and Rotterdam: Can Durban, Rio de Janeiro drive India’s next export boom?The South-South trade has crossed $7 trillion, opening new opportunities for Indian exporters across Africa, ASEAN, the Gulf, and Latin Ame...
- Three Indian companies under US Senators' scanner for data 'theft' allegationsUS Senators have urged action against three India-based companies for alleged hacking. These firms reportedly stole data from thousands of ...
- Prasol Chemicals IPO Day 2: GMP, subscription status. Should you subscribe?Prasol Chemicals IPO saw 72% subscription by Day 2, with retail investors showing strong interest. The grey market premium remains modest a...
- Sun Pharma incorporates global treasury arm at IFSC, GIFT CityOn September 8, 2026, Sun Pharmaceutical Industries Ltd announced the establishment of its new subsidiary, Sun Pharma Global Treasury Centr...
- Tata Capital Healthcare Fund to exit Linux Laboratories as ChrysCapital buys 20-25% stakePrivate equity firm ChrysCapital is set to acquire a significant stake in Linux Laboratories. This deal will see existing investor Tata Cap...
- Biocon shares: Active Pine may divest up to 1% equity worth Rs 638 crore via block dealActive Pine is likely to sell up to 1.66 crore Biocon shares, worth Rs 638 crore, through a block deal at Rs 385 per share. The development...
- Sun Pharma gets ratings boost from Moody's, S&P over USD 11.75-bn Organon & Co acquisition bidRating agencies Moody's and S&P assigned investment-grade ratings to Sun Pharmaceutical Industries. This action follows Sun Pharma's propos...
- Prasol Chemicals IPO opens for bidding. Check GMP and other key detailsThe Prasol Chemicals IPO opened for subscription on September 8 and will remain open until September 10. The Rs 500 crore issue comprises a...
- Karnataka woos French companies for investments in manufacturing, R&D and aerospace sectorsKarnataka is seeking French investment in manufacturing and emerging sectors. Discussions were held with Roquette, bioMerieux, and Hutchins...
- US dollar reserve shift may be less widespread than headline figures suggest, NY Fed study findsThe dollar’s share of global reserves has fallen, but a New York Fed study says the decline is concentrated among a few countries. Reserve ...
- Waterfield Advisors launches two GIFT City funds for global diversificationWaterfield Advisors has launched two GIFT City-based outbound AIFs to help Indian family portfolios diversify across global equities, commo...
- Pharma sector must attract more investment in clinical trials, R&D: Piyush GoyalPiyush Goyal emphasized the importance of enhancing India's pharmaceutical industry to draw in more investments. He urged for the creation ...
- Life on Earth has always used four DNA letters, but scientists have created a bigger genetic alphabet and found something unexpectedScientists have demonstrated RNA polymerase can read eight genetic letters. This enzyme accurately transcribes synthetic DNA, which nature ...
- Karnataka signs MoU with INQ Innovation Global to strengthen collaboration with New South WalesThe state of Karnataka is joining forces with New South Wales in Australia to bolster their innovation ecosystems. This agreement will faci...
- Cohance Lifesciences to invest USD 18 mn in NJ Bio, Aruka BioCohance Lifesciences announced an eighteen million dollar investment to strengthen its antibody-drug conjugate strategy. This includes thir...
- Sun Pharma agrees to lower US drug prices under Trump plan; analysts see limited financial impactSun Pharmaceutical Industries will offer its drugs at prices matching other developed nations. This agreement aims to make healthcare affor...
- Geopolitical shocks are forcing companies to rethink procurement intelligence: Claight CEOGeopolitical tensions, tariff uncertainty and repeated supply-chain disruptions are pushing global companies to move from periodic procurem...
Load More
